• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善类风湿关节炎患者的生活质量:甲氨蝶呤联合疼痛专项护理干预。

Enhancing Quality of Life in Rheumatoid Arthritis Patients: A Combined Approach of Methotrexate and Pain-specific Nursing Intervention.

出版信息

Altern Ther Health Med. 2024 Oct;30(10):404-408.

PMID:38401073
Abstract

BACKGROUND

Rheumatoid arthritis (RA) is a chronic autoimmune disorder affecting joint health and patients' overall well-being. While methotrexate (MTX) is a standard therapeutic intervention, enhancing its efficacy with pain-specific nursing remains underexplored.

OBJECTIVE

This study aims to assess the impact of combining MTX with pain-specific nursing on patients with RA, providing valuable insights for clinical practice and offering an improved therapeutic approach to alleviate pain and enhance the overall quality of life for affected individuals.

METHODS

We conducted a prospective cohort study, choosing a cohort of 86 RA patients admitted to our hospital from March 2021 to March 2023. After treatment, we compared the number of swollen and painful joints, duration of morning stiffness, and scores on the Visual Analogue Scale (VAS), Pittsburgh Sleep Quality Index (PSQI), and Self-rating Anxiety Scale/Self-rating Depression Scale (SAS/SDS) between the two groups. Nursing satisfaction was surveyed upon discharge, and patient quality of life was assessed using the 36-item Short Form Health Survey (SF-36).

RESULTS

The research group exhibited a notable decrease in the number of swollen and painful joints, significantly shorter morning stiffness duration, and marked reductions in VAS, PSQI, SAS, and SDS scores compared to the control group (P < .05). Additionally, nursing satisfaction and SF-36 scores were higher in the research group (P < .05).

CONCLUSIONS

The combination of MTX and pain-specific nursing effectively alleviated pain and improved the quality of life and nursing satisfaction among RA patients.

摘要

背景

类风湿关节炎(RA)是一种影响关节健康和患者整体健康的慢性自身免疫性疾病。甲氨蝶呤(MTX)是一种标准的治疗干预措施,但与疼痛特异性护理相结合以提高其疗效仍未得到充分探索。

目的

本研究旨在评估将 MTX 与疼痛特异性护理相结合对 RA 患者的影响,为临床实践提供有价值的见解,并提供一种改善的治疗方法,以减轻疼痛并提高受影响个体的整体生活质量。

方法

我们进行了一项前瞻性队列研究,选择了 2021 年 3 月至 2023 年 3 月期间我院收治的 86 例 RA 患者作为队列。治疗后,我们比较了两组患者肿胀和疼痛关节的数量、晨僵持续时间、视觉模拟量表(VAS)、匹兹堡睡眠质量指数(PSQI)和焦虑自评量表/抑郁自评量表(SAS/SDS)评分。出院时进行护理满意度调查,并使用 36 项简明健康状况调查问卷(SF-36)评估患者的生活质量。

结果

研究组肿胀和疼痛关节数量明显减少,晨僵持续时间明显缩短,VAS、PSQI、SAS 和 SDS 评分明显降低,与对照组相比差异有统计学意义(P<0.05)。此外,研究组的护理满意度和 SF-36 评分较高(P<0.05)。

结论

MTX 联合疼痛特异性护理可有效缓解 RA 患者的疼痛,提高生活质量和护理满意度。

相似文献

1
Enhancing Quality of Life in Rheumatoid Arthritis Patients: A Combined Approach of Methotrexate and Pain-specific Nursing Intervention.改善类风湿关节炎患者的生活质量:甲氨蝶呤联合疼痛专项护理干预。
Altern Ther Health Med. 2024 Oct;30(10):404-408.
2
Patient-reported health outcomes in a trial of etanercept monotherapy versus combination therapy with etanercept and methotrexate for rheumatoid arthritis: the ADORE trial.在一项关于类风湿关节炎的试验中,对比依那西普单药治疗与依那西普联合甲氨蝶呤治疗的患者报告健康结局:ADORE试验
Ann Rheum Dis. 2008 Aug;67(8):1104-10. doi: 10.1136/ard.2006.068585. Epub 2007 Jul 31.
3
Clinical, autoimmune, and psychiatric parameters correlate with sleep disturbance in patients with systemic sclerosis and rheumatoid arthritis.临床、自身免疫和精神参数与系统性硬化症和类风湿关节炎患者的睡眠障碍相关。
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):49-55. Epub 2016 May 10.
4
Health-related quality of life outcomes of adalimumab for patients with early rheumatoid arthritis: results from a randomized multicenter study.阿达木单抗治疗早期类风湿关节炎患者的健康相关生活质量结局:一项随机多中心研究的结果。
J Rheumatol. 2012 Jan;39(1):63-72. doi: 10.3899/jrheum.101161. Epub 2011 Nov 1.
5
Methotrexate for treating rheumatoid arthritis.甲氨蝶呤用于治疗类风湿关节炎。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD000957. doi: 10.1002/14651858.CD000957.pub2.
6
Efficacy and safety of methotrexate plus hydroxychloroquine combination therapy vs. methotrexate monotherapy in the treatment of rheumatoid arthritis: A randomized controlled clinical trial.甲氨蝶呤联合羟氯喹与甲氨蝶呤单药治疗类风湿关节炎的疗效和安全性:一项随机对照临床试验。
Int J Rheum Dis. 2024 Sep;27(9):e15319. doi: 10.1111/1756-185X.15319.
7
Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.在已确诊类风湿关节炎的亚洲人群中,与常规 DMARD 治疗相比,依那西普可改善健康结局。
BMC Musculoskelet Disord. 2013 Jan 8;14:13. doi: 10.1186/1471-2474-14-13.
8
Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.利妥昔单抗对未曾接受甲氨蝶呤治疗的类风湿关节炎患者的身体功能和生活质量的影响。
Arthritis Care Res (Hoboken). 2011 May;63(5):711-20. doi: 10.1002/acr.20419.
9
Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept.接受依那西普治疗的类风湿关节炎、早期类风湿关节炎和早期银屑病关节炎患者的健康相关生活质量和残疾情况。
Qual Life Res. 2010 Aug;19(6):821-6. doi: 10.1007/s11136-010-9651-3. Epub 2010 Apr 6.
10
[Clinical study of Biqi Capsule combined with methotrexate for treatment of rheumatoid arthritis].痹祺胶囊联合甲氨蝶呤治疗类风湿关节炎的临床研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Feb;32(2):195-8.